Conmed Corp (CNMD)

EBITDA

$185.52M

TTM · Period ending: · USD

CNMD logo

CNMD EBITDA

Latest reported$185.52M
CNMD TTM EBITDA ($1.40M → $185.52M)
High-resolution chart · PNG

CNMD ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Conmed Corp EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
185,524,000
181,050,000
176,972,000
192,004,000
240,220,000
248,364,000
267,204,000
264,889,000
234,360,000
214,897,000
192,479,000
140,931,000
134,633,000
18,921,000
27,563,000
65,615,000
66,533,000
180,250,000
179,333,000
167,286,000
171,750,000
125,131,000
118,278,000
119,916,000
112,831,000
152,995,000
146,249,000
143,380,000
130,442,000
125,338,000
133,108,000
130,354,000
131,452,000
126,582,000
105,483,000
93,526,000
92,960,000
87,618,000
105,685,000
103,518,000
101,817,000
103,427,000
95,054,000
99,319,000
87,419,000
91,468,000
98,520,000
98,224,000
104,589,000
104,952,000
104,112,000
110,529,000
115,819,000
105,138,000
94,824,000
28,028,000
28,903,000
39,250,000
49,831,000
103,814,000
102,834,000
98,315,000
94,555,000
92,476,000
80,355,000
70,466,000
62,413,000
69,270,000
73,219,000
82,874,000
88,124,000
93,025,000
92,398,000
88,634,000
90,834,000
27,488,000
29,447,000
29,432,000
17,323,000
64,564,000
70,227,000
78,749,000
95,273,000
87,297,000
88,747,000
89,107,000
90,029,000
119,323,000
118,739,000
107,444,000
112,709,000
99,615,000
99,824,000
109,349,000
101,719,000
103,903,000
101,700,000
100,042,000
99,106,000
99,652,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.